News & Articles

The fully automated solution replaces labor-intensive manual workflows, reducing turnaround times and supporting faster, standardized, high-quality care

Find out why millions of cases of hepatitis B and C are going undiagnosed and how clinical labs could play an important role in getting more people tested and treated

Simoa HD-X receives MFDS Class I IVD Import Clearance, enabling the first clinical introduction of Simoa technology in Korea

The new subsidiary is expected to accelerate broader adoption of Seegene’s developing solutions, CURECA™ and STAgora™, in Europe

Dr. Barbara Jones, CEO of CLSI, discusses emerging resistance trends, the importance of updated breakpoints, and how CLSI continues to support laboratories navigating the evolving AMR landscape

The new PCR test aids in the diagnosis of infectious causes of vaginitis through the detection of bacteria associated with bacterial vaginosis and yeast associated with candida vaginitis

Experts discuss the evolving landscape of clinical mass spectrometry, the impact of automation, challenges in integration, and what the future holds

University of Cambridge researcher spotlights a novel radiotracer during ELRIG Drug Discovery 2025

The point-of-care test detects and differentiates between three types of Bordetella infection that can cause similar cough symptoms, ensuring patients receive the right diagnosis at the earliest opportunity

Test helps to identify patients at high risk who need intervention or closer monitoring

Stanford Cancer Center South Bay streamlines chemistry test delivery with CLSI AUTO15, boosting lab efficiency and patient care

Part two of the Quality Data, Informed Action webinar series explores how informatics and essential quality indicators can enhance patient safety

Our one day social media takeover on Linkedin

Dr. Manu De Rycker, a Principal Investigator at the University of Dundee, has been named as the newest winner of the WH Pierce Global Impact in Microbiology Prize

Take the survey and submit a guest editorial

Test will serve as a companion diagnostic for Bayer’s HYRNUO™ (sevabertinib) to identify patients with non-small cell lung cancer eligible for HER2-targeted therapy

Developed by a physician-led team, the panel arrives pre-plated in a 96-well format and features a modular, breakaway design to reduce waste and streamline lab workflows

New generation of allergen tests to support faster, more accurate diagnosis worldwide

Dr. Richard Knight, medical director of transplant diagnostics at Thermo Fisher Scientific explores personalized, non‑invasive approaches designed to improve transplant success

A study from Karl Landsteiner University of Health Sciences demonstrates HIFU effectively controls prostate cancer and maintains patients’ quality of life.

First-of-its-kind, automated system delivers increased sensitivity, specific identification of disease markers and improved laboratory workflow to support fast, confident diagnoses

Findings from the study reveal how a repair system inside some bacteria plays a pivotal role in helping them survive commonly-used antibiotics

Guest editorial features key takeaways from Balancing the Future Podcast, episode 9, by METTLER TOLEDO